Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 352

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 1
Chunk 352
---
53
     
    Chief
    Financial Officer, Treasurer, and Secretary
  
    Matthew
    Pratt Whalen, CPA
     
    45
     
    Director
  
    Matthew
    Paul Del Giudice, M.D.
     
    43
     
    Director
  
    Craig
    Eagle, M.D.
     
    57
     
    Director
  
    Edward
    MacPherson
     
    36
     
    Director

The
following is a brief biography of each of our current executive officers and directors:

55

Executive
Officers and Directors

Erez
Aminov has served as our Chief Executive Officer and Chairman since August 2024. Mr. Aminov is an experienced biotechnology consultant
and is also the Chief Executive Officer of MIRA Pharmaceuticals Inc. (“MIRA”). Mr. Aminov’s experience in the biotech
consulting sector began in 2021 when he founded Locate Venture Corp. in September 2021.  Locate Venture is a strategy and investment
consulting firm focused on advancing and supporting early-stage biotech startups. Prior to founding Locate Venture Corp., from February
2015 to September 2020, Mr. Aminov served as the President of Finds4less Inc., a global distributor of electronics and gaming products.
In this role, Mr. Aminov provided strategic oversight and direction for all aspects of the company’s operations, while also spearheading
new business development initiatives to capitalize on emerging market opportunities. Mr. Aminov’s more than two decades of experience
includes experience with the biotech industry’s particular challenges, including creating strategic alliances and guiding startups
toward growth and prosperity. Mr. Aminov earned a B.A. in Accounting from Touro University in New York. We believe that Mr. Aminov is
qualified to serve as one of our directors based on his finance and investment experience, particularly with early stage life sciences
companies.

Michelle
Yanez, MBA has served as our Chief Financial Officer since June 2024, and also currently serves as the Chief Financial Officer
of MIRA Pharmaceuticals. Ms. Yanez is a senior financial executive with over 25 years of experience in public and privately held biotech,
pharmaceutical, and life science companies. Ms. Yanez’ experience includes a broad range of responsibilities in a highly complex
and regulated market. She also brings deep corporate governance experience through her work with corporate boards, including audit